Abstract
A strong inhibition of the serine protease thrombin, important in the blood coagulation process, was achieved through de novo designed inhibitors. The most active compound is shown. The X-ray crystal structure of the thrombin–inhibitor complex showed the binding mode of these compounds and confirmed that only the enantiomer predicted by computer modeling was bound in the active site.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Angewandte Chemie International Edition in English
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
